• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血栓性血小板减少性紫癜/溶血性尿毒症综合征:预测血浆置换反应的因素的多变量分析

Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange.

作者信息

Pereira A, Mazzara R, Monteagudo J, Sanz C, Puig L, Martínez A, Ordinas A, Castillo R

机构信息

Service of Hemotherapy and Hemostasis, Hospital Clínico, Barcelona, Spain.

出版信息

Ann Hematol. 1995 Jun;70(6):319-23. doi: 10.1007/BF01696619.

DOI:10.1007/BF01696619
PMID:7632812
Abstract

The aim of this study was to investigate pretreatment prognostic factors that could be useful in predicting the response to plasma exchange in thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS). Thirty-two patients with TTP/HUS, treated with plasma exchange at our institution from 1980 to 1994, were studied. The main clinical and laboratory data at the beginning of plasma exchanges were analyzed by the Cox stepwise logistic regression, applied to either treatment failure or death. Seventeen (53%) patients attained a complete remission and 22 (69%) survived (five in advanced renal failure and long-term hemodialysis). Longer delay in initiating plasma exchanges, presence of stupor or coma, and higher creatinine levels at the beginning of plasma exchanges were independent predictors of treatment failure. Stupor or coma at the beginning of plasma exchanges was the only predictor of mortality from unremitted TTP/HUS. Hemoglobin levels, platelet count, and LDH activity, traditionally envisaged as markers of disease activity, neither correlated with previous duration of TTP/HUS nor had any prognostic value. Early diagnosis of TTP/HUS and prompt initiation of intensive plasma exchange emerged from this study as the most effective interventions for improving the prognosis of TTP/HUS patients.

摘要

本研究的目的是调查在血栓性血小板减少性紫癜/溶血尿毒综合征(TTP/HUS)中,有助于预测血浆置换反应的预处理预后因素。对1980年至1994年在我院接受血浆置换治疗的32例TTP/HUS患者进行了研究。通过Cox逐步逻辑回归分析血浆置换开始时的主要临床和实验室数据,将其应用于治疗失败或死亡情况。17例(53%)患者实现完全缓解,22例(69%)存活(5例处于晚期肾衰竭并长期接受血液透析)。开始血浆置换的时间延迟较长、存在木僵或昏迷以及血浆置换开始时肌酐水平较高是治疗失败的独立预测因素。血浆置换开始时的木僵或昏迷是TTP/HUS未缓解导致死亡的唯一预测因素。传统上被视为疾病活动标志物的血红蛋白水平、血小板计数和乳酸脱氢酶活性,既与TTP/HUS之前的病程无关,也没有任何预后价值。本研究表明,TTP/HUS的早期诊断和及时开始强化血浆置换是改善TTP/HUS患者预后的最有效干预措施。

相似文献

1
Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange.血栓性血小板减少性紫癜/溶血性尿毒症综合征:预测血浆置换反应的因素的多变量分析
Ann Hematol. 1995 Jun;70(6):319-23. doi: 10.1007/BF01696619.
2
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients.血栓性血小板减少性紫癜-溶血尿毒综合征(TTP-HUS):178 例患者 24 年的临床经验。
J Hematol Oncol. 2008 Dec 1;1:23. doi: 10.1186/1756-8722-1-23.
3
[Clinical analysis on thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, with plasma level of cytokine].血栓性血小板减少性紫癜和溶血尿毒综合征伴细胞因子血浆水平的临床分析
Rinsho Ketsueki. 1990 Sep;31(9):1537-43.
4
High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.高剂量血浆输注与血浆置换作为血栓性血小板减少性紫癜/溶血尿毒综合征的早期治疗方法
Medicine (Baltimore). 2003 Jan;82(1):27-38. doi: 10.1097/00005792-200301000-00003.
5
Pathophysiology and treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS).血栓性血小板减少性紫癜/溶血尿毒综合征(TTP/HUS)的病理生理学与治疗
Int J Hematol. 2000 Jun;71(4):320-7.
6
[Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome].[微血管病性溶血性贫血。14例血栓性血小板减少性紫癜和溶血尿毒综合征患者的临床模式、治疗及临床病程]
Schweiz Med Wochenschr. 1986 Nov 29;116(48):1666-74.
7
Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases.血栓性血小板减少性紫癜/溶血性尿毒症综合征(TTP/HUS):治疗结果、复发情况及预后因素。48例单中心经验。
Ann Hematol. 2000 Feb;79(2):66-72. doi: 10.1007/s002770050012.
8
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.血栓性血小板减少性紫癜-溶血性尿毒症综合征:病理生理学与管理
Nephrol Nurs J. 2002 Apr;29(2):171-80; quiz 181-2.
9
How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.我如何治疗血栓性血小板减少性紫癜-溶血性尿毒症综合征患者。
Blood. 2000 Aug 15;96(4):1223-9.
10
Pathophysiology and management of thrombotic microangiopathies.血栓性微血管病的病理生理学与管理
J Nephrol. 1998 Nov-Dec;11(6):300-10.

引用本文的文献

1
Delayed Recovery of a Disintegrin-Like and Metalloproteinase With Thrombospondin Type 1 Motif 13 (ADAMTS13) Activity in Immune Thrombotic Thrombocytopenic Purpura Treated With Caplacizumab and Rituximab.在接受卡泊单抗和利妥昔单抗治疗的免疫性血栓性血小板减少性紫癜中,含血小板反应蛋白基序的解聚素样金属蛋白酶13(ADAMTS13)活性延迟恢复
Cureus. 2025 Feb 12;17(2):e78884. doi: 10.7759/cureus.78884. eCollection 2025 Feb.
2
How We Interpret Thrombosis with Thrombocytopenia Syndrome?我们如何解读血栓性血小板减少性紫癜?
Int J Mol Sci. 2024 May 1;25(9):4956. doi: 10.3390/ijms25094956.
3
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura.

本文引用的文献

1
Effect of splenectomy on von Willebrand factor multimeric structure in thrombotic thrombocytopenic purpura refractory to plasma exchange.脾切除术对血浆置换难治性血栓性血小板减少性紫癜中血管性血友病因子多聚体结构的影响。
Blood Coagul Fibrinolysis. 1993 Oct;4(5):783-6.
2
Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.成人血栓性血小板减少性紫癜-溶血性尿毒症综合征患者的治疗结果
Arch Intern Med. 1994 May 9;154(9):982-7.
3
Thrombotic thrombocytopenic purpura: a thirty year review.
一种用于预测免疫性血栓性血小板减少性紫癜所致死亡率的机器学习方法。
Res Pract Thromb Haemost. 2024 Mar 19;8(3):102388. doi: 10.1016/j.rpth.2024.102388. eCollection 2024 Mar.
4
Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023.日本 2023 年血栓性血小板减少性紫癜(TTP)的诊断和治疗指南。
Int J Hematol. 2023 Nov;118(5):529-546. doi: 10.1007/s12185-023-03657-0. Epub 2023 Sep 10.
5
Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的病理生理学与管理前沿
Int J Hematol. 2023 Mar;117(3):331-340. doi: 10.1007/s12185-023-03552-8. Epub 2023 Feb 9.
6
Systemic Lupus Erythematosus Presenting With Thrombotic Thrombocytopenic Purpura at Onset: A Case Report.系统性红斑狼疮起病时伴血栓性血小板减少性紫癜:一例报告
Front Pediatr. 2022 Aug 1;10:931669. doi: 10.3389/fped.2022.931669. eCollection 2022.
7
Proteinuria Increases the PLASMIC and French Scores Performance to Predict Thrombotic Thrombocytopenic Purpura in Patients With Thrombotic Microangiopathy Syndrome.蛋白尿可提高PLASMIC评分和法国评分预测血栓性微血管病综合征患者血栓性血小板减少性紫癜的效能。
Kidney Int Rep. 2021 Nov 16;7(2):221-231. doi: 10.1016/j.ekir.2021.11.009. eCollection 2022 Feb.
8
Deleterious neurological impact of diagnostic delay in immune-mediated thrombotic thrombocytopenic purpura.免疫介导性血栓性血小板减少性紫癜诊断延迟的有害神经影响。
PLoS One. 2021 Nov 19;16(11):e0260196. doi: 10.1371/journal.pone.0260196. eCollection 2021.
9
Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management.血栓性血小板减少性紫癜:病理生理学、诊断与管理
J Clin Med. 2021 Feb 2;10(3):536. doi: 10.3390/jcm10030536.
10
A case of thrombotic microangiopathy of unknown aetiology, clinically presenting as an acute surgical abdomen.一例病因不明的血栓性微血管病,临床表现为急性急腹症。
BMJ Case Rep. 2019 Nov 28;12(11):e230553. doi: 10.1136/bcr-2019-230553.
Semin Thromb Hemost. 1980;6(4):350-5. doi: 10.1055/s-2007-1005108.
4
Thrombotic thrombocytopenic purpura: analysis of 48 unselected cases.
Semin Thromb Hemost. 1980;6(4):341-9. doi: 10.1055/s-2007-1005107.
5
High incidence of relapses in thrombotic thrombocytopenic purpura. Clinical study of 38 patients.血栓性血小板减少性紫癜复发率高。38例患者的临床研究。
Am J Med. 1987 Sep;83(3):437-44. doi: 10.1016/0002-9343(87)90753-4.
6
Thrombotic thrombocytopenic purpura: treatment with plasmapheresis.
Am J Hematol. 1987 Apr;24(4):329-39. doi: 10.1002/ajh.2830240402.
7
Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.血栓性血小板减少性紫癜与溶血尿毒综合征:发病机制与治疗的演变概念
Clin Haematol. 1986 May;15(2):413-42.
8
HUS and TTP: variable expression of a single entity.溶血尿毒综合征和血栓性血小板减少性紫癜:单一疾病实体的可变表现。
Kidney Int. 1987 Aug;32(2):292-308. doi: 10.1038/ki.1987.206.
9
Prostacyclin in thrombotic microangiopathy.血栓性微血管病中的前列环素
Semin Hematol. 1987 Apr;24(2):110-8.
10
Role of fibrinolysis in thrombotic thrombocytopenic purpura.
Semin Hematol. 1987 Apr;24(2):101-9.